Similar articles for PMID: 29144001

Year	Number of Results
2003	1
2004	1
2005	3
2006	3
2007	4
2008	5
2009	4
2010	3
2011	6
2012	5
2013	7
2014	5
2015	9
2016	24
2017	21
2018	21
2019	19
2020	22
2021	19
2022	19
2023	4
2024	0

1

Biological evaluation and energetic analyses of novel GSK-3β inhibitors.

Zhang D, Liu L, Pang L, Jin Q, Ke K, Hu M, Yang J, Ma W, Xie H, Chen X. Zhang D, et al. J Cell Biochem. 2018 Apr;119(4):3510-3518. doi: 10.1002/jcb.26522. Epub 2017 Dec 26. J Cell Biochem. 2018. PMID: 29144001

2

Receptor-based pharmacophore modeling, virtual screening, and molecular docking studies for the discovery of novel GSK-3β inhibitors.

El Kerdawy AM, Osman AA, Zaater MA. El Kerdawy AM, et al. J Mol Model. 2019 May 25;25(6):171. doi: 10.1007/s00894-019-4032-5. J Mol Model. 2019. PMID: 31129879

3

(Z)-2-(3-Chlorobenzylidene)-3,4-dihydro-N-(2-methoxyethyl)-3-oxo-2H-benzo[b][1,4]oxazine-6-carboxamide as GSK-3β inhibitor: Identification by virtual screening and its validation in enzyme- and cell-based assay.

Joshi P, Gupta M, Vishwakarma RA, Kumar A, Bharate SB. Joshi P, et al. Chem Biol Drug Des. 2017 Jun;89(6):964-971. doi: 10.1111/cbdd.12913. Epub 2017 Feb 16. Chem Biol Drug Des. 2017. PMID: 27896926

4

Docking, molecular dynamics, binding energy-MM-PBSA studies of naphthofuran derivatives to identify potential dual inhibitors against BACE-1 and GSK-3β.

Kumar A, Srivastava G, Negi AS, Sharma A. Kumar A, et al. J Biomol Struct Dyn. 2019 Feb;37(2):275-290. doi: 10.1080/07391102.2018.1426043. Epub 2018 Jan 19. J Biomol Struct Dyn. 2019. PMID: 29310523

5

Discovery of new GSK-3β inhibitors through structure-based virtual screening.

Dou X, Jiang L, Wang Y, Jin H, Liu Z, Zhang L. Dou X, et al. Bioorg Med Chem Lett. 2018 Jan 15;28(2):160-166. doi: 10.1016/j.bmcl.2017.11.036. Epub 2017 Nov 24. Bioorg Med Chem Lett. 2018. PMID: 29208522

6

Design, Synthesis and Biological Evaluation of 7-Chloro-9H-pyrimido[4,5-b]indole-based Glycogen Synthase Kinase-3β Inhibitors.

Andreev S, Pantsar T, Ansideri F, Kudolo M, Forster M, Schollmeyer D, Laufer SA, Koch P. Andreev S, et al. Molecules. 2019 Jun 25;24(12):2331. doi: 10.3390/molecules24122331. Molecules. 2019. PMID: 31242571 Free PMC article.

7

A physicochemical descriptor based method for effective and rapid screening of dual inhibitors against BACE-1 and GSK-3β as targets for Alzheimer's disease.

Kumar A, Srivastava G, Sharma A. Kumar A, et al. Comput Biol Chem. 2017 Dec;71:1-9. doi: 10.1016/j.compbiolchem.2017.09.001. Epub 2017 Sep 8. Comput Biol Chem. 2017. PMID: 28950235

8

E-pharmacophore-based virtual screening to identify GSK-3β inhibitors.

Natarajan P, Priyadarshini V, Pradhan D, Manne M, Swargam S, Kanipakam H, Bhuma V, Amineni U. Natarajan P, et al. J Recept Signal Transduct Res. 2016 Oct;36(5):445-58. doi: 10.3109/10799893.2015.1122043. Epub 2015 Dec 20. J Recept Signal Transduct Res. 2016. PMID: 27305963

9

Investigation of naphthofuran moiety as potential dual inhibitor against BACE-1 and GSK-3β: molecular dynamics simulations, binding energy, and network analysis to identify first-in-class dual inhibitors against Alzheimer's disease.

Kumar A, Srivastava G, Srivastava S, Verma S, Negi AS, Sharma A. Kumar A, et al. J Mol Model. 2017 Aug;23(8):239. doi: 10.1007/s00894-017-3396-7. Epub 2017 Jul 24. J Mol Model. 2017. PMID: 28741112

10

Identifying GSK-3β kinase inhibitors of Alzheimer's disease: Virtual screening, enzyme, and cell assays.

Lin CH, Hsieh YS, Wu YR, Hsu CJ, Chen HC, Huang WH, Chang KH, Hsieh-Li HM, Su MT, Sun YC, Lee GC, Lee-Chen GJ. Lin CH, et al. Eur J Pharm Sci. 2016 Jun 30;89:11-9. doi: 10.1016/j.ejps.2016.04.012. Epub 2016 Apr 14. Eur J Pharm Sci. 2016. PMID: 27094783

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

172 results

Results by year